UNLABELLED: Methods: Leptin levels were measured in 103 consecutive women with anorexia nervosa. Results: Spine BMD and Z-score values were found to be significantly lower in the low tertile compared with the highest tertile. Duration of amenorrhea and leptin level accounted for 27% of the variance in lumbar spine BMD. INTRODUCTION: The purpose of this study was to assess leptin levels and other biological variables in a population of anorexia nervosa patients. METHODS: Leptin levels were measured consecutively in 103 women with anorexia nervosa (AN) with a mean age of 24.9 +/- 7.4 years. Osteodensitometry was also performed by dual energy X-ray absorptiometry (DXA). RESULTS: Spine bone mineral density (BMD) and Z-score values were found to be significantly lower in the low tertile compared with the highest tertile. Duration of amenorrhea and leptin level accounted for 27% of the variance in lumbar spine BMD. The mean leptin level was 3.9 +/- 4.6 ng/mL (normal values, 3.5-11 ng/mL). The distribution of leptin values was not a Gaussian distribution, and a log-transformed was therefore performed. A significant correlation was found between leptin level and spinal BMD (r = 0.3; p = 0.002); significant correlations were observed for both femoral neck and total hip BMDs. When leptin level values were divided into tertiles, spine BMD and Z-score values were found to be significantly lower in the lower tertile (p = 0.04 and p = 0.02) compared with the highest tertile. For femoral neck BMDs, the T-score was slightly lower between low and high tertile, but the difference was not statistically significant (p = 0.07). When multivariate analyses were performed, two independent factors which could possibly account for the variance in spinal BMDs were found. Duration of amenorrhea and leptin level accounted for 27% of the variance (p < 0.0001). CONCLUSION: The mechanisms underlying bone loss in AN patients remain unclear and complex, involving hypoestrogenia as well as nutritional factors such as insulin-like growth factor and leptin.
UNLABELLED: Methods:Leptin levels were measured in 103 consecutive women with anorexia nervosa. Results: Spine BMD and Z-score values were found to be significantly lower in the low tertile compared with the highest tertile. Duration of amenorrhea and leptin level accounted for 27% of the variance in lumbar spine BMD. INTRODUCTION: The purpose of this study was to assess leptin levels and other biological variables in a population of anorexia nervosapatients. METHODS:Leptin levels were measured consecutively in 103 women with anorexia nervosa (AN) with a mean age of 24.9 +/- 7.4 years. Osteodensitometry was also performed by dual energy X-ray absorptiometry (DXA). RESULTS: Spine bone mineral density (BMD) and Z-score values were found to be significantly lower in the low tertile compared with the highest tertile. Duration of amenorrhea and leptin level accounted for 27% of the variance in lumbar spine BMD. The mean leptin level was 3.9 +/- 4.6 ng/mL (normal values, 3.5-11 ng/mL). The distribution of leptin values was not a Gaussian distribution, and a log-transformed was therefore performed. A significant correlation was found between leptin level and spinal BMD (r = 0.3; p = 0.002); significant correlations were observed for both femoral neck and total hip BMDs. When leptin level values were divided into tertiles, spine BMD and Z-score values were found to be significantly lower in the lower tertile (p = 0.04 and p = 0.02) compared with the highest tertile. For femoral neck BMDs, the T-score was slightly lower between low and high tertile, but the difference was not statistically significant (p = 0.07). When multivariate analyses were performed, two independent factors which could possibly account for the variance in spinal BMDs were found. Duration of amenorrhea and leptin level accounted for 27% of the variance (p < 0.0001). CONCLUSION: The mechanisms underlying bone loss in AN patients remain unclear and complex, involving hypoestrogenia as well as nutritional factors such as insulin-like growth factor and leptin.
Authors: Madhusmita Misra; Karen K Miller; Kelly Kuo; Kathryn Griffin; Victoria Stewart; Emily Hunter; David B Herzog; Anne Klibanski Journal: Am J Physiol Endocrinol Metab Date: 2005-04-05 Impact factor: 4.310
Authors: S Grinspoon; T Gulick; H Askari; M Landt; K Lee; E Anderson; Z Ma; L Vignati; R Bowsher; D Herzog; A Klibanski Journal: J Clin Endocrinol Metab Date: 1996-11 Impact factor: 5.958
Authors: P Ducy; M Amling; S Takeda; M Priemel; A F Schilling; F T Beil; J Shen; C Vinson; J M Rueger; G Karsenty Journal: Cell Date: 2000-01-21 Impact factor: 41.582
Authors: M Yamauchi; T Sugimoto; T Yamaguchi; D Nakaoka; M Kanzawa; S Yano; R Ozuru; T Sugishita; K Chihara Journal: Clin Endocrinol (Oxf) Date: 2001-09 Impact factor: 3.478
Authors: Isabelle Legroux-Gérot; Jean Vignau; Michèle D'Herbomez; Francis Collier; Xavier Marchandise; Bernard Duquesnoy; Bernard Cortet Journal: Calcif Tissue Int Date: 2007-08-01 Impact factor: 4.333
Authors: L Maïmoun; S Guillaume; P Lefebvre; P Philibert; H Bertet; M-C Picot; L Gaspari; F Paris; M Seneque; A-M Dupuys; P Courtet; E Thomas; D Mariano-Goulart; J Bringer; E Renard; C Sultan Journal: Osteoporos Int Date: 2015-08-06 Impact factor: 4.507
Authors: P K Fazeli; A T Faje; E Meenaghan; S T Russell; M Resulaj; H Lee; C J Rosen; M L Bouxsein; A Klibanski Journal: Osteoporos Int Date: 2019-10-28 Impact factor: 4.507